NASDAQ NMS - GLOBAL MARKET · ENLV
-9.64% · -$0.0300 · Vol 2.8M
Market closed · last close 4:00 PM ET · price as of 19:56:31 ET
Enlivex Ltd

Enlivex Ltd

Biotechnology
$0.2503
Card
Relationship Map

Follow $ENLV

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ENLV by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Valuation absence reason unknown
ENLV
Enlivex Ltd
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

40/ 100
Veridion Score
Lower range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ENLV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ENLV catalysts
About Enlivex Ltd
Biotechnology
Listed since
2014
Employees
34
Country
IL

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.2500
Day high
$0.2826
Day low
$0.2240
Previous close
$0.2770
52W high
$18.15
-98.62% from high
52W low
$0.2240
0% of range
Market cap
$5.5M
P/E
0.00×
EPS
$149.75
Beta
0.40
Shares out
19.9M
Volume
2.8M
1.60× rel vol
Avg volume
1.7M
VWAP
$0.2518
Price history computed in-house
1W
-35.37%
1M
-74.48%
3M
-96.35%
1Y
-98.55%
YTD
-97.63%
SMA 50 $1.16 · below
SMA 200 $9.61 · below
52W position 0%

ENLV overview

Veridion Score
40
Registered · 2026-10-09
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ENLV.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ENLV Form 4 filings
Public disclosures

Congress activity in ENLV

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

ENLV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENLV in this window.
Lobbying spend

ENLV lobbying filings, year to date.

Registered lobbying filings matched to Enlivex Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENLV in this window.
Loading news for ENLV
Analyst ratings
Sovereign unlock shows live analyst consensus for ENLV.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.